A modular, multi-arm, first in human trial to evaluate the safety and tolerability of MDX-124 alone and in combination with anti-cancer treatments, in participants with locally advanced, unresectable or metastatic solid malignancies (ATTAINMENT)

Principal Investigator

Prof Sarah Blagden

Contact us

Email: orh-tr.earlyphasenurses@nhs.net

IRAS number

1005488